Clinical Trials Logo

Postherpetic Neuralgia clinical trials

View clinical trials related to Postherpetic Neuralgia.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06232486 Active, not recruiting - Clinical trials for Postherpetic Neuralgia

Relationship Between Serum Vitamin D Levels and Postherpetic Neuralgia.

Start date: December 1, 2023
Phase:
Study type: Observational

1. The correlations of serum vitamin D level, serum calcium level and osteoporosis degree with disease severity, treatment response, incidence of Post-Herpes zoster(PHN) and disease prognosis in Herpes zoster(HZ) patients were studied. 2. To investigate the role of inflammation-related factors and immune-related factors in the occurrence and development of HZ mediated by low vitamin D level.

NCT ID: NCT05517486 Active, not recruiting - Clinical trials for Postherpetic Neuralgia

Single-dose to Evaluate the Pharmacokinetics of GTX-101 and Subcutaneous Injectable Bupivacaine in Healthy Subjects

Start date: July 26, 2022
Phase: Phase 1
Study type: Interventional

This is a single-center, randomized, single-dose, active-controlled study in healthy male and female subjects. The study will enroll subjects to evaluate the PK of 3 dose strengths (50 mg, 100 mg and 200 mg) of GTX-101 compared to Subcutaneous injection in healthy adult subjects. Blood samples for PK assessments will be collect at specified time points. Safety assessments will also be performed throughout the study.

NCT ID: NCT01508676 Active, not recruiting - Neuralgia Clinical Trials

Effects of Pennsaid on Clinical Neuropathic Pain

Start date: November 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to see if the drug Pennsaid (Diclofenac) can help reduce pain felt by people with chronic nerve pain. The drug will be used 2-4 times each day for 2 weeks. The U.S. Food and Drug Administration (FDA) has approved Pennsaid to treat osteoarthritis (bone pain), but the FDA has not approved Pennsaid to treat neuropathic (nerve) pain. The research study will compare Pennsaid to placebo.

NCT ID: NCT00813826 Active, not recruiting - Clinical trials for Postherpetic Neuralgia

Efficacy and Safety Study of SLC022 in Treating Pain Associated With Post Herpetic Neuralgia

Start date: January 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of SLC022 in treating pain associated with post-herpetic neuralgia (PHN) in recently diagnosed patients.

NCT ID: NCT00652184 Active, not recruiting - Herpes Zoster Clinical Trials

Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)

Start date: March 2008
Phase: Phase 2
Study type: Interventional

A multi-center, randomized, 4-arm, placebo-controlled, double-blind efficacy study of ARYS-01 (sorivudine) cream 3%.